Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities

被引：24

作者：

Mohsin, Noor Ul Amin ^{[1
]}

Aslam, Sana ^{[2
]}

Ahmad, Matloob ^{[3
]}

Irfan, Muhammad ^{[4
]}

Al-Hussain, Sami A. ^{[5
]}

Zaki, Magdi E. A. ^{[5
]}

机构：

[1] Govt Coll Univ, Fac Pharmaceut Sci, Dept Pharmaceut Chem, Faisalabad 38000, Pakistan

[2] Govt Coll Women Univ, Dept Chem, Faisalabad 38000, Pakistan

[3] Govt Coll Univ, Dept Chem, Faisalabad 38000, Pakistan

[4] Govt Coll Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Faisalabad 38000, Pakistan

[5] Imam Mohammad Ibn Saud Islamic Univ IMSIU, Fac Sci, Dept Chem, Riyadh 11623, Saudi Arabia

来源：

PHARMACEUTICALS | 2022年 / 15卷 / 12期

关键词：

drug design; hybrid molecules; cancer cell lines; molecular docking; COX-2; IN-VITRO; BIOLOGICAL EVALUATION; MOLECULAR DOCKING; DUAL INHIBITORS; ANTITUMOR ACTIVITIES; NATURAL-PRODUCTS; CANCER; DERIVATIVES; DESIGN; DISCOVERY;

D O I：

10.3390/ph15121471

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Cancer is a serious threat to human beings and is the second-largest cause of death all over the globe. Chemotherapy is one of the most common treatments for cancer; however, drug resistance and severe adverse effects are major problems associated with anticancer therapy. New compounds with multi-target inhibitory properties are targeted to surmount these challenges. Cyclooxygenase-2 (COX-2) is overexpressed in cancers of the pancreas, breast, colorectal, stomach, and lung carcinoma. Therefore, COX-2 is considered a significant target for the synthesis of new anticancer agents. This review discusses the biological activity of recently prepared dual anticancer and COX-2 inhibitory agents. The most important intermolecular interactions with the COX-2 enzyme have also been presented. Analysis of these agents in the active area of the COX-2 enzyme could guide the introduction of new lead compounds with extreme selectivity and minor side effects.

引用

页数：41

共 130 条

[1] Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities
Abd El Razik, Heba A.
Mroueh, Mohamad
Faour, Wissam H.
Shebaby, Wassim N.
Daher, Costantine F.
Ashour, Hayam M. A.
Ragab, Hanan M.
[J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (01) : 83 - 96
[2] Synthesis and anti-inflammatory activity of sulfonamides and carboxylates incorporating trimellitimides: Dual cyclooxygenase/carbonic anhydrase inhibitory actions
Abdel-Aziz, Alaa A. -M.
Angeli, Andrea
El-Azab, Adel S.
Hammouda, Mohammed E. A.
El-Sherbeny, Magda A.
Supuran, Claudiu T.
[J]. BIOORGANIC CHEMISTRY, 2019, 84 : 260 - 268
[3] Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities
Abdelazeem, Ahmed H.
El-Saadi, Mohammed T.
Said, Eman G.
Youssif, Bahaa G. M.
Omar, Hany A.
El-Moghazy, Samir M.
[J]. BIOORGANIC CHEMISTRY, 2017, 75 : 127 - 138
[4] Novel Phenolic Compounds as Potential Dual EGFR and COX-2 Inhibitors: Design, Semisynthesis, in vitro Biological Evaluation and in silico Insights
Abdelgawad, Mohamed A.
Musa, Arafa
Almalki, Atiah H.
Alzarea, Sami, I
Mostafa, Ehab M.
Hegazy, Mostafa M.
Mostafa-Hedeab, Gomaa
Ghoneim, Mohammed M.
Parambi, Della Gt
Bakr, Rania B.
Al-Muaikel, Nayef S.
Alanazi, Abdullah S.
Alharbi, Metab
Ahmad, Waqas
Bukhari, Syed Na
Al-Sanea, Mohammad M.
[J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 2325 - 2337
[5] New pyrimidine-benzoxazole/benzimidazole hybrids: Synthesis, antioxidant, cytotoxic activity, in vitro cyclooxygenase and phospholipase A2-V inhibition
Abdelgawad, Mohamed A.
Bakr, Rania B.
Ahmad, Waqas
Al-Sanea, Mohammad M.
Elshemy, Heba A. H.
[J]. BIOORGANIC CHEMISTRY, 2019, 92
[6] Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents
Abdelgawad, Mohamed A.
Bakr, Rania B.
Omar, Hany A.
[J]. BIOORGANIC CHEMISTRY, 2017, 74 : 82 - 90
[7] Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities
Abdellatif, Khaled R. A.
Fadaly, Wael A. A.
Mostafa, Yaser A.
Zaher, Dana M.
Omar, Hany A.
[J]. BIOORGANIC CHEMISTRY, 2019, 91
[8] Design, synthesis and biological evaluation of novel indanone containing spiroisoxazoline derivatives with selective COX-2 inhibition as anticancer agents
Abolhasani, Hoda
Zarghi, Afshin
Movahhed, Tahereh Komeili
Abolhasani, Ahmad
Daraei, Bahram
Dastmalchi, Siavoush
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 32
[9] Achiwa H, 1999, CLIN CANCER RES, V5, P1001
[10] Design, Synthesis, and Biological Evaluation of New Peptide Analogues as Selective COX-2 Inhibitors
Ahmaditaba, Mohammad A.
Shahosseini, Soraya
Daraei, Bahram
Zarghi, Afshin
Tehrani, Mohammad H. Houshdar
[J]. ARCHIV DER PHARMAZIE, 2017, 350 (10)

← 1 2 3 4 5 6 7 8 9 10 →